Profile data is unavailable for this security.
About the company
Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.
- Revenue in INR (TTM)6.24bn
- Net income in INR1.33bn
- Incorporated1989
- Employees338.00
- LocationAdvanced Enzyme Technologies LtdSun-Magnetica, A Wing, 5th FloorLIC Service Road, LouiswadiTHANE 400604IndiaIND
- Phone+91 2 241703200
- Fax+91 2 225835159
- Websitehttps://www.advancedenzymes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd | 25.80bn | -1.54bn | 25.20bn | 1.30k | -- | -- | 17.10 | 0.9767 | -9.84 | -9.84 | 164.35 | -- | -- | -- | -- | 19,919,850.00 | -- | 0.4699 | -- | 0.5665 | 76.93 | 74.36 | -5.98 | 1.82 | -- | -0.1245 | -- | 202.76 | 12.72 | 7.32 | -265.46 | -- | 21.54 | -- |
| SeQuent Scientific Ltd | 13.70bn | -358.69m | 25.77bn | 478.00 | -- | 3.92 | 80.70 | 1.88 | -1.45 | -1.45 | 56.27 | 26.37 | 0.8925 | 2.19 | 4.05 | -- | -1.93 | 1.09 | -3.27 | 1.76 | 44.53 | 42.74 | -2.16 | 1.18 | 0.7602 | 0.1376 | 0.4062 | -- | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 27.01bn | 1.23k | -- | 85.42 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Innova Captab Ltd | 10.81bn | 943.45m | 27.50bn | -- | 26.92 | -- | 24.93 | 2.54 | 17.85 | 17.85 | 202.59 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 32.64 | 25.95 | 8.73 | 8.04 | -- | 6.45 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Indoco Remedies Ltd | 18.17bn | 984.70m | 27.70bn | 6.10k | 28.56 | 2.50 | 14.66 | 1.52 | 10.52 | 10.52 | 193.15 | 120.38 | 0.9557 | 1.65 | 4.80 | -- | 5.10 | 6.88 | 7.02 | 9.85 | 69.23 | 66.66 | 5.34 | 6.93 | 0.9825 | 4.01 | 0.377 | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Supriya Lifescience Ltd | 5.70bn | 1.19bn | 29.54bn | 392.00 | 24.80 | 3.62 | 21.89 | 5.18 | 14.80 | 14.80 | 70.87 | 101.31 | 0.655 | 2.21 | 5.81 | -- | 13.68 | 19.08 | 15.19 | 24.04 | 61.12 | 58.71 | 20.88 | 24.71 | 4.06 | 66.40 | 0.0067 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Gufic BioSciences Ltd | 8.07bn | 861.36m | 30.89bn | 1.63k | 35.20 | 5.80 | 29.94 | 3.83 | 8.75 | 8.75 | 81.90 | 53.11 | 0.8258 | 2.03 | 3.01 | -- | 8.82 | 11.46 | 13.32 | 19.21 | 51.67 | 46.99 | 10.68 | 10.46 | 1.08 | 8.37 | 0.3847 | -- | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
| Hikal Ltd | 17.85bn | 696.00m | 35.12bn | 2.14k | 50.42 | 2.96 | 18.76 | 1.97 | 5.65 | 5.65 | 144.77 | 96.32 | 0.7325 | 2.66 | 3.60 | -- | 2.86 | 5.07 | 4.03 | 7.51 | 53.79 | 47.22 | 3.90 | 5.86 | 0.8761 | 2.65 | 0.4077 | 16.88 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
| Unichem Laboratories Ltd | 17.05bn | -704.74m | 38.21bn | 3.12k | -- | 1.62 | 89.35 | 2.24 | -10.02 | -10.02 | 238.88 | 335.54 | 0.5359 | 0.9995 | 2.84 | -- | -2.22 | -1.67 | -2.81 | -2.03 | 61.02 | 57.79 | -4.13 | -3.99 | 1.40 | -0.5733 | 0.0948 | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
| Advanced Enzyme Technologies Ltd | 6.24bn | 1.33bn | 40.57bn | 338.00 | 30.41 | 3.06 | 23.56 | 6.50 | 11.93 | 11.93 | 55.83 | 118.41 | 0.4219 | 1.06 | 6.27 | -- | 9.26 | 10.82 | 10.23 | 11.93 | 76.83 | 72.81 | 21.95 | 24.59 | 6.22 | 57.81 | 0.0334 | 15.17 | 15.39 | 8.26 | 26.19 | 3.72 | 27.85 | 53.42 |
| Aarti Drugs Ltd | 25.29bn | 1.71bn | 43.84bn | 1.50k | 25.63 | 3.42 | 19.66 | 1.73 | 18.61 | 18.61 | 274.44 | 139.40 | 1.04 | 3.35 | 3.22 | -- | 7.07 | 9.73 | 10.98 | 15.74 | 33.65 | 24.96 | 6.79 | 8.25 | 1.05 | 7.91 | 0.3056 | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Shilpa Medicare Ltd | 11.51bn | 318.74m | 47.49bn | 1.03k | 131.96 | 2.33 | 33.96 | 4.12 | 3.68 | 3.68 | 134.51 | 208.37 | 0.3841 | 1.23 | 3.21 | -- | 1.07 | 2.84 | 1.41 | 3.65 | 64.63 | 61.37 | 2.78 | 7.03 | 0.7671 | 1.41 | 0.3424 | -- | 9.66 | 9.44 | 198.15 | -22.26 | -9.26 | -- |
| Orchid Pharma Ltd | 8.19bn | 915.95m | 50.86bn | 838.00 | 52.39 | 4.35 | 39.82 | 6.21 | 19.14 | 19.14 | 169.90 | 230.58 | 0.5897 | 1.97 | 3.99 | -- | 6.80 | -0.9734 | 8.80 | -1.40 | 40.87 | 43.32 | 11.53 | -2.40 | 2.03 | 4.68 | 0.1031 | -- | 23.05 | 6.43 | 73.59 | 5.84 | 57.79 | -- |
| Aarti Pharmalabs Ltd | 18.53bn | 2.17bn | 50.93bn | 1.40k | 23.48 | 2.90 | 17.56 | 2.75 | 23.94 | 23.94 | 204.45 | 193.89 | 0.7698 | 1.64 | 3.86 | -- | 9.01 | -- | 12.30 | -- | 44.90 | -- | 11.71 | -- | 1.01 | 18.17 | 0.1397 | -- | -4.76 | -- | 12.10 | -- | -- | -- |
Data as of Jun 05 2024. Currency figures normalised to Advanced Enzyme Technologies Ltd's reporting currency: Indian Rupee INR
6.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Apr 2024 | 4.03m | 3.60% |
| ICICI Prudential Asset Management Co. Ltd.as of 30 Apr 2024 | 1.97m | 1.77% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 615.91k | 0.55% |
| BlackRock Fund Advisorsas of 09 May 2024 | 186.70k | 0.17% |
| BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 163.10k | 0.15% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Apr 2024 | 99.78k | 0.09% |
| Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 2024 | 78.56k | 0.07% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 63.14k | 0.06% |
| Dimensional Fund Advisors Ltd.as of 31 Mar 2024 | 58.18k | 0.05% |
| TIAA-CREF Investment Management LLCas of 31 Mar 2024 | 45.11k | 0.04% |
More ▼
Data from 31 Mar 2024 - 30 May 2024Source: FactSet Research Systems Inc.
